MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 240 filers reported holding MEDIVATION INC in Q1 2014. The put-call ratio across all filers is 1.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $26,961,000 | -24.1% | 208,889 | -41.5% | 1.02% | -35.8% |
| Q4 2014 | $35,541,000 | +6.7% | 356,806 | +5.9% | 1.59% | +13.7% |
| Q3 2014 | $33,307,000 | +4121.4% | 336,878 | +3192.1% | 1.40% | +4148.5% |
| Q2 2014 | $789,000 | -96.8% | 10,233 | -97.4% | 0.03% | -96.9% |
| Q4 2013 | $24,811,000 | -59.2% | 388,760 | -61.6% | 1.07% | -63.4% |
| Q3 2013 | $60,751,000 | -54.6% | 1,013,529 | -62.7% | 2.92% | -26.1% |
| Q2 2013 | $133,685,000 | – | 2,717,173 | – | 3.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |